ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04933	AGE-RAGE signaling pathway in diabetic complications	11/140	135/7206	5.74865206702e-05
ko04710	Circadian rhythm	6/140	43/7206	0.000162970986047
ko04020	Calcium signaling pathway	15/140	265/7206	0.000180458354869
ko04068	FoxO signaling pathway	11/140	167/7206	0.000381506182032
ko05146	Amoebiasis	8/140	99/7206	0.000642287803583
ko04014	Ras signaling pathway	14/140	279/7206	0.000996777645926
ko04931	Insulin resistance	9/140	137/7206	0.00133012338881
ko04070	Phosphatidylinositol signaling system	8/140	112/7206	0.0014442576026
ko05166	HTLV-I infection	14/140	292/7206	0.00154258091492
ko05223	Non-small cell lung cancer	6/140	66/7206	0.00168534842636
ko04910	Insulin signaling pathway	10/140	172/7206	0.0018292019325
ko04360	Axon guidance	12/140	233/7206	0.00184748780367
ko04218	Cellular senescence	10/140	177/7206	0.00226142563144
ko04350	TGF-beta signaling pathway	7/140	103/7206	0.00377621784242
ko04930	Type II diabetes mellitus	5/140	54/7206	0.00379573577217
ko05321	Inflammatory bowel disease (IBD)	5/140	56/7206	0.00444515996159
ko04010	MAPK signaling pathway	14/140	321/7206	0.00528467552054
ko05212	Pancreatic cancer	6/140	83/7206	0.00535267107964
ko05220	Chronic myeloid leukemia	6/140	85/7206	0.00600994164006
ko05418	Fluid shear stress and atherosclerosis	9/140	173/7206	0.00638973887
ko04261	Adrenergic signaling in cardiomyocytes	10/140	205/7206	0.00643356514172
ko04013	MAPK signaling pathway - fly	7/140	115/7206	0.00689286536895
ko04921	Oxytocin signaling pathway	10/140	209/7206	0.00734232546956
ko05206	MicroRNAs in cancer	9/140	177/7206	0.00739072712799
ko04920	Adipocytokine signaling pathway	6/140	89/7206	0.00749838002142
ko04960	Aldosterone-regulated sodium reabsorption	4/140	41/7206	0.00791876048042
ko04668	TNF signaling pathway	7/140	120/7206	0.00864130388554
ko04022	cGMP-PKG signaling pathway	10/140	216/7206	0.00916902446217
ko05211	Renal cell carcinoma	6/140	96/7206	0.0107172294618
ko04015	Rap1 signaling pathway	12/140	278/7206	0.0115028841725
ko04725	Cholinergic synapse	8/140	160/7206	0.0124710812742
ko04152	AMPK signaling pathway	8/140	161/7206	0.0129138570353
ko05410	Hypertrophic cardiomyopathy (HCM)	6/140	100/7206	0.0129435393448
ko05142	Chagas disease (American trypanosomiasis)	7/140	130/7206	0.0130869485107
ko04071	Sphingolipid signaling pathway	8/140	162/7206	0.0133680857164
ko04140	Autophagy - animal	8/140	164/7206	0.0143115581407
ko01521	EGFR tyrosine kinase inhibitor resistance	6/140	106/7206	0.0168636773628
ko05200	Pathways in cancer	17/140	492/7206	0.0172371106322
ko05214	Glioma	5/140	79/7206	0.0184205515086
ko05230	Central carbon metabolism in cancer	5/140	81/7206	0.0203113292672
ko04919	Thyroid hormone signaling pathway	7/140	143/7206	0.0210664760552
ko04371	Apelin signaling pathway	8/140	177/7206	0.0216653055532
ko04320	Dorso-ventral axis formation	3/140	31/7206	0.02168899207
ko04213	Longevity regulating pathway - multiple species	5/140	86/7206	0.0255820978175
ko05210	Colorectal cancer	5/140	86/7206	0.0255820978175
ko04917	Prolactin signaling pathway	5/140	87/7206	0.0267319652789
ko00562	Inositol phosphate metabolism	5/140	89/7206	0.0291296306552
ko04270	Vascular smooth muscle contraction	7/140	154/7206	0.0300639714539
ko05213	Endometrial cancer	4/140	62/7206	0.031966450709
ko04211	Longevity regulating pathway	6/140	123/7206	0.0322357335185
ko04810	Regulation of actin cytoskeleton	10/140	264/7206	0.0375536657591
ko04922	Glucagon signaling pathway	6/140	128/7206	0.0380736543086
ko00254	Aflatoxin biosynthesis	1/140	2/7206	0.038481695511
ko05205	Proteoglycans in cancer	10/140	271/7206	0.0422275954681
ko05231	Choline metabolism in cancer	6/140	134/7206	0.045922086762